• Work with us
  • External Contractors
Fondazione Toscana Life Sciences
  • IT
  • EN
Toscana Life Sciences
  • THE FOUNDATION
    • Organization
    • History
    • Membership
    • The Legislative Decree No. 231/2001
  • Activity
  • Cluster
  • ITS VITA
  • BIOINCUBATOR
    • Join the Bioincubator
    • Incubated companies
    • Research groups
    • Affiliated companies
  • Services
    • Business development services
    • Research services
    • Incubation services
    • Protection of intellectual property
  • Projects
    • ERC Advanced Grant OMVac
    • Monoclonal Antibody Discovery (MAD) LAB
    • ERC Advanced Grant VACCIBIOME
    • My First AIRC grant @Tumour Immunology Unit
    • Regions4PerMed
    • COSME-AI4DIAG
    • IDF SHARID
    • BORNTOGEtTHERe
    • SINO-EU‐PERMED
    • Orphan diseases
  • Disseminating
    • TLS Open Doors
    • Scientists for a day
    • Science + Economy = Business
    • Researcher’s Night
    • European Biotech Week
  • TLS4Covid19
  • Stories
Enter any keyword and press enter

Vittoria Zucconi

  • Projects
    • ERC Advanced Grant OMVac
    • Monoclonal Antibody Discovery (MAD) LAB
    • ERC Advanced Grant VACCIBIOME
    • My First AIRC grant @Tumour Immunology Unit
    • Regions4PerMed
    • COSME-AI4DIAG
    • IDF SHARID
    • BORNTOGEtTHERe
    • SINO-EU‐PERMED
< Back to MAD LAB

Vittoria Zucconi

Vittoria is part of the Biochemistry and Molecular Biology PhD Program of the University of Siena and joined the research group headed by Dr. Rino Rappuoli at Toscana Life Sciences (TLS) in november 2020. She obtained a Bachelor’s degree in Chemistry at Sapienza University of Rome and continued her study career with a Master’s degree in Cellular and Molecular Biology and Biomedical Sciences at Tor Vergata University of Rome. During her Master’s thesis project, Vittoria focused on the role of a bacterial toxin in colorectal cancer onset and development, highlighting a relation between such toxin and neoplastic transformation. More specifically, she analyzed the toxin’s capacity of causing DNA damage and inducing modifications that can facilitate tumor progression.
Vittoria will be working on identification and isolation of human monoclonal antibodies as new therapeutic approaches against anti-microbial resistant pathogens responsible for bowel infections.

Fondazione Toscana Life Sciences
Via Fiorentina, 1
53100 Siena – ITALIA

  • tel +39 0577 231211
  • fax +39 0577 43444
  • info@toscanalifesciences.org; info@pec.fondazionetls.org

Twitter Feeds

Europa chiama Cina per vincere insieme una nuova sfida di salute internazionale. In campo anche la Fondazione Tosca…

@FondazioneTLS 4 Days Ago

🔎Oggi, mercoledì 7 aprile, si celebra la Giornata mondiale della salute. L'OMS lancia l'appello sulla necessità di…

@FondazioneTLS 5 Days Ago

Il viaggio di @Radio1Rai all'interno di Tls prosegue in compagnia della Dottoressa Claudia Sala, responsabile del…

@FondazioneTLS 6 Days Ago

Contatti

    Concedo il consenso al trattamento dei dati personali secondo la nostra Privacy Policy per poter essere contattato da Fondazione Toscana Life Sciences.

©2015-2021 - Fondazione Toscana Life Sciences - P.I. 01194710529 - Codice SDI: SUBM70N - Privacy - Cookie Policy